Novavax Inc. sell JPMorgan Chase & Co.
Start price
09.05.25
/
50%
€5.45
Target price
09.05.26
€6.24
Performance (%)
59.39%
End price
10.05.26
€8.69
Summary
This prediction ended on 10.05.26 with a price of €8.69. The price for Novavax Inc. massively increased, which is bad news for the SELL prediction by JPMorgan_Chase___Co_. JPMorgan_Chase___Co_ has a follow-up prediction for Novavax Inc. where he still thinks Novavax Inc. is a Sell. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novavax Inc. | 3.786% | 3.786% | 42.703% |
| iShares Core DAX® | 1,35 % | 0,93 % | 6,81 % |
| iShares Nasdaq 100 | 3,28 % | 4,99 % | 41,20 % |
| iShares Nikkei 225® | 7,43 % | 16,60 % | 70,50 % |
| iShares S&P 500 | 1,70 % | 2,24 % | 27,28 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Novavax Inc. diskutieren
Novavax, Inc. (NASDAQ: NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $9.00 to $7.00. They now have an "underweight" rating on the stock.
Ratings data for NVAX provided by MarketBeat
In the thread Trading Novavax Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten